
Sterile ophthalmic solutions and suspensions in multi-dose dropper bottles and preservative-free single-dose units, covering the anti-infective and ocular-surface categories referenced in WHO and MSF eye-care guidance.

Sterile ophthalmic solutions and suspensions in multi-dose dropper bottles and preservative-free single-dose units, covering the anti-infective and ocular-surface categories referenced in WHO and MSF eye-care guidance.
Ophthalmic products face a tighter container specification than any other common dosage form. The WHO Model List names ofloxacin and gentamicin eye drops for conjunctivitis and infectious keratitis, and WHO has issued a specific safety notice for ophthalmic chlorhexidine — a reminder that in eye care the container and the concentration are part of the safety case.
Ofloxacin 0.3% and gentamicin 0.3% eye drops are the listed anti-infectives, for conjunctivitis and infectious keratitis. The wider range we supply spans anti-allergic, anti-inflammatory, antiviral and ocular-surface categories.
Yes. Single-dose preservative-free units and multi-dose bottles with a preservative system are both quoted, with the corresponding preservative efficacy or sterility data in the dossier.
LDPE dropper bottles with a tamper-evident cap for multi-dose presentations, or sealed single-dose units where a preservative must be avoided. Nozzle geometry and drop volume are part of the agreed specification.
Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.
Send a requirement · full product catalogue · therapeutic ranges
Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.